IIPLA News
Wednesday, April 29, 2026

Munich UPC Division Clarifies Claim Interpretation for Medical Devices in Emboline v. AorticLab Dispute

Court finds no infringement of Emboline’s embolic protection device patent, emphasizing the significance of normal professional use in medical device claims.

IIPLA News Deskanonymous access0 articles left this week
UPC Claim Interpretation: The Normal Use Of A Medical Device Matters
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

The Munich Local Division of the Unified Patent Court has ruled in favor of AorticLab srl, finding no infringement of Emboline Inc.'s patent for an embolic protection device. The decision underscores the importance of interpreting claim features in light of normal professional use, particularly for medical devices. Th…
Share This Article
Ready-to-post copy includes the article link.

Munich UPC Division Clarifies Claim Interpretation for Medical Devices in Emboline v. AorticLab Dispute The Munich Local Division of the Unified Patent Court has ruled in favor of AorticLab srl, finding no infringement of Emboline Inc.'s patent for an embolic protection device. The decision underscores the importance of i... Read the full IIPLA article: https://iipla.org/news/munich-upc-division-clarifies-claim-interpretation-for-medical-devices-in-emboline-v-aorticlab-dispute

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Nigeria Advances Intellectual Property Reforms to Boost Economic Growth and Innovation

The Nigerian Federal Government is intensifying efforts to leverage intellectual property as a catalyst for economic development, investment, and job creation. Through collaboration with the World Intellectual Property Organization (WIPO) and the rollout of the Industrial Property Administration System (IPAS), Nigeria…

Thursday, May 28, 2026
PatentsGlobal

Procopio’s Patent Practice and Five Partners Earn Spots on 2026 IAM Patent 1000 List

Procopio’s patent prosecution team and five intellectual property partners have been named to the prestigious 2026 IAM Patent 1000 list. The recognition highlights the firm’s strengths in life sciences, AI, emerging technologies, and trade secrets, underscoring its integrated approach to patent portfolio development a…

Thursday, May 28, 2026